Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Japan Diabetes Market Report: 2020-2025

Market Overview:

The Japan diabetes market reached a value of US$ 4.34 Billion in 2019. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2020-2025. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use industries. These insights are included in the report as a major market contributor.

Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes. 

Japan Diabetes Market Drivers:

With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.

Breakup by Segment:

  • Oral Antidiabetics
  • Insulin


Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.

Key Questions Answered in This Report:

  • How has the Japan diabetes market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan diabetes market?
  • Which are the popular segments in the Japan diabetes market?
  • What are the various stages in the value chain of the Japan diabetes market?
  • What are the key driving factors and challenges in the Japan diabetes market?
  • What is the structure of the Japan diabetes market and who are the key players?
  • What is the degree of competition in the Japan diabetes market?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1 Overview
    4.2 Key Industry Trends
5   Diabetes Disease Overview
    5.1 What is Diabetes?
    5.2 Diabetes Diagnosis and Treatment
        5.2.1 Diagnosis
        5.2.2 Treatment
    5.3 Diabetes Complications
6   Japan Diabetes Epidemiology
    6.1 Diabetes Population and Prevalence Rates
    6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    6.3 Population and Prevalence Rates by Region
    6.4 Population and Prevalence Rates by Gender
    6.5 Population and Prevalence Rates by Age Group
7   Japan Diabetes Market
    7.1 Market Overview 
    7.2 Market Performance
    7.3 Impact of COVID-19
    7.4 Market Forecast
    7.5 SWOT Analysis
        7.5.1 Overview
        7.5.2 Strengths
        7.5.3 Weaknesses
        7.5.4 Opportunities
        7.5.5 Threats
    7.6 Value Chain Analysis
    7.7 Porter’s Five Forces Analysis
        7.7.1 Overview
        7.7.2 Bargaining Power of Buyers
        7.7.3 Bargaining Power of Suppliers
        7.7.4 Degree of Competition
        7.7.5 Threat of New Entrants
        7.7.6 Threat of Substitutes
     7.8 Market Breakup by Segment
        7.8.1 Japan Oral Antidiabetics Market
            7.8.1.1 Historical Market Trends
            7.8.1.2 Market Breakup by Class
            7.8.1.3 Market Shares of Key Players
            7.8.1.4 Market Forecast
        7.8.2 Japan Insulin Market
            7.8.2.1 Historical Market Trends
            7.8.2.2 Market Breakup by Class
            7.8.2.3 Market Shares of Key Players
            7.8.2.4 Market Forecast
8   Competitive Landscape
    8.1 Competitive Structure
    8.2 Profiles of Key Players 

List of Figures

Figure 1: The Impact of Diabetes in the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Breakup of Diabetes Patients by Region, (in %) 2019 & 2025
Figure 4: Body Mass Index and Relative risk of Type-2 Diabetes
Figure 5: Japan: Total Number of Diabetes Patients (in 000), 2014-2019
Figure 6: Japan: Total Number of Diabetes Patients Forecast (in 000), 2020-2025
Figure 7: Japan (Type1 & Type2): Total Number of Diabetes Patients (in 000), 2014-2019
Figure 8: Japan (Type1 & Type2): Total Number of Diabetes Patients Forecast (in 000), 2020-2025
Figure 9: Japan (Urban & Rural): Total Number of Diabetes Patients (in 000), 2014-2019
Figure 10: Japan (Urban & Rural): Total Number of Diabetes Patients Forecast (in 000), 2020-2025
Figure 11: Japan (Male & Female): Total Number of Diabetes Patients (in 000), 2014-2019
Figure 12: Japan (Male & Female): Total Number of Diabetes Patients Forecast (in 000), 2020-2025
Figure 13: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2014-2019
Figure 14: Japan: Total Number of Diabetes Patients Forecast by Age Group (20-39), (40-59) & (60-79) (in 000), 2020-2025
Figure 15: Japan: Diabetes Drug Industry Overview
Figure 16: Japan: Diabetes Drug Market: Sales Value (in Million US$), 2014-2019
Figure 17: Japan: Diabetes Drug Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Japan: Diabetes Drug Market: SWOT Analysis
Figure 19: Japan: Diabetes Drug Market: Value Chain Analysis
Figure 20: Japan: Diabetes Drug Market: Porters Five Forces Analysis
Figure 21: Japan: Diabetes Drug Market: Breakup of Insulin and Oral Antidiabetics (in %), 2014-2019
Figure 22: Japan: Diabetes Drug Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2020-2025
Figure 23: Japan: Oral Antidiabetics Market: Sales Value (in Million US$), 2014-2019
Figure 24: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2014 & 2019
Figure 25: Japan: Oral Anti-diabetics Market: Sales Share of Key Players (in %)
Figure 26: Japan: Oral Antidiabetics Market Forecast: Sales Value (in Million US$) 2020-2025
Figure 27: Japan: Insulin Market: Sales Value (in Million US$), 2014-2019
Figure 28: Japan: Breakup of Insulin Market by Class (in %), 2019
Figure 29: Japan: Insulin Market: Sales Share of Key Players (in %)
Figure 30: Japan: Insulin Market Forecast: Sales Value (in Million US$), 2020-2025
 
List of Tables

Table 1: Diagnosis of Diabetes
Table 2: Global: Diabetes Population Breakup by Country (in 000’s), 2019 and 2025
Table 3: Japan: Total Prevalence & Number of Diabetes Patients, 2014, 2019 & 2025
Table 4: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2014, 2019 & 2025
Table 5: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2014, 2019 & 2025
Table 6: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2014, 2019 & 2025
Table 7: Japan: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79 - In Millions), 2014, 2019 & 2025
Table 8: Japan: Diabetes Drug Market: Competitive Structure

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links